Exosomes as novel bio-carriers for gene and drug delivery.
暂无分享,去创建一个
[1] J. Le Pecq,et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.
[2] Chad A. Mirkin,et al. Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.
[3] H. Geuze,et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.
[4] Shunsuke Noguchi,et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] Toshihiko Yamashita,et al. Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma , 2005, Journal of Translational Medicine.
[6] Ralph Weissleder,et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.
[7] R. Zhou,et al. IFITM3‐containing exosome as a novel mediator for anti‐viral response in dengue virus infection , 2014, Cellular microbiology.
[8] A. Boer,et al. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier , 2007, Clinical pharmacokinetics.
[9] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[10] T. D. de Gruijl,et al. Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.
[11] M. Czyz,et al. MiRNA in melanoma-derived exosomes. , 2014, Cancer letters.
[12] Sung Wan Kim,et al. Efficient siRNA Delivery with Non-viral Polymeric Vehicles , 2009, Pharmaceutical Research.
[13] R. Zhuo,et al. Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. , 2015, Langmuir : the ACS journal of surfaces and colloids.
[14] Sungho Jin,et al. Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.
[15] Robert Langer,et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.
[16] M. V. Filatov,et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro , 2013, Cell Communication and Signaling.
[17] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[18] I. Sargent,et al. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. , 2012, Placenta.
[19] M. Chopp,et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. , 2015, Journal of neurosurgery.
[20] M. Chopp,et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] Per Sunnerhagen,et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.
[22] Cobi J. Heijnen,et al. Exosomes: A New Weapon to Treat the Central Nervous System , 2013, Molecular Neurobiology.
[23] W. Ding,et al. Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.
[24] J. Garssen,et al. Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures , 2014, Journal of extracellular vesicles.
[25] W. Hammerschmidt,et al. EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL , 2011, PloS one.
[26] Imre Mäger,et al. Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.
[27] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] H. Yin,et al. Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro , 2016, Hepatology.
[29] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[30] R. Johnstone,et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.
[31] P. Altevogt,et al. Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment , 2015, Oncoimmunology.
[32] R. Simpson,et al. Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.
[33] M. Wood,et al. Exosomes for targeted siRNA delivery across biological barriers. , 2013, Advanced drug delivery reviews.
[34] Jaesung Park,et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.
[35] Daehee Hwang,et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells , 2009, BMC Genomics.
[36] Richard J Simpson,et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.
[37] Meg Duroux,et al. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.
[38] Y. Tabata,et al. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[39] P. Sims,et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.
[40] Christian Pilarsky,et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.
[41] D. Maria,et al. Evaluation in melanoma‐bearing mice of an etoposide derivative associated to a cholesterol‐rich nanoemulsion , 2006, The Journal of pharmacy and pharmacology.
[42] M. Record,et al. Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.
[43] J. Lötvall,et al. Isolation and Characterization of RNA-Containing Exosomes , 2012, Journal of visualized experiments : JoVE.
[44] Q. Ping,et al. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. , 2009, International journal of pharmaceutics.
[45] Y. Tabata,et al. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[46] Myung Soo Kim,et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[47] Aled Clayton,et al. Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.
[48] J. Baulch,et al. Cranial grafting of stem cell-derived microvesicles improves cognition and reduces neuropathology in the irradiated brain , 2016, Proceedings of the National Academy of Sciences.
[49] A. Möller,et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma , 2015, Journal of extracellular vesicles.
[50] Michael Liem,et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma , 2013, Proteomics.
[51] J. Lötvall,et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles , 2013, Journal of extracellular vesicles.
[52] Jun Qin,et al. Functions and application of exosomes. , 2014, Acta poloniae pharmaceutica.
[53] Ashutosh Chilkoti,et al. Co‐opting biology to deliver drugs , 2014, Biotechnology and bioengineering.
[54] S. Pluchino,et al. Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases , 2015, Biogerontology.
[55] Shinobu Ueda,et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[56] R. Schiffelers,et al. Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.
[57] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[58] J. Lötvall,et al. The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles , 2014, Journal of extracellular vesicles.
[59] R. Schiffelers,et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[60] Aled Clayton,et al. Adhesion and signaling by B cell‐derived exosomes: the role of integrins , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] B. Pan,et al. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor , 1983, Cell.
[63] C. Mirkin,et al. Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents. , 2014, Small.
[64] Clotilde Théry,et al. Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.
[65] György Nagy,et al. Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .
[66] G. Raposo,et al. Exosomes: a common pathway for a specialized function. , 2006, Journal of biochemistry.
[67] Mauro Ferrari,et al. Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.
[68] E. Bieberich,et al. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease , 2014, Neurobiology of Aging.
[69] Susanne Gabrielsson,et al. Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro , 2011, The Journal of Immunology.
[70] Olivier Lantz,et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.
[71] Richa Gupta,et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[72] D. Momekova,et al. Star-shaped nano-conjugates of cisplatin with high drug payload. , 2011, International journal of pharmaceutics.
[73] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[74] Aiman S Saab,et al. Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron Communication , 2013, PLoS biology.
[75] G. Raposo,et al. As we wait: coping with an imperfect nomenclature for extracellular vesicles , 2013, Journal of extracellular vesicles.
[76] S. Tyagi,et al. Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. , 2014, Life sciences.
[77] M. Chopp,et al. Exosomes in stroke pathogenesis and therapy. , 2016, The Journal of clinical investigation.
[78] M. Setou,et al. Functionalized nano-magnetic particles for an in vivo delivery system. , 2007, Journal of nanoscience and nanotechnology.
[79] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[80] Silvia Maria Doglia,et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[81] Y. Tabata,et al. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. , 2012, Molecular pharmaceutics.
[82] R. Setterquist,et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.
[83] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[84] J. Gehl,et al. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.
[85] Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics , 2014, Molecular Neurobiology.
[86] Jacco van Rheenen,et al. In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.
[87] M. Ashraf,et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. , 2013, Biochemical and biophysical research communications.
[88] M. Wood,et al. Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.
[89] Jun Lu,et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.
[90] Raghu Kalluri,et al. Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.
[91] Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases , 2013, Metabolic Brain Disease.
[92] Qiang Zhou,et al. Cellular Internalization of Exosomes Occurs Through Phagocytosis , 2010, Traffic.
[93] Y. Tabata,et al. Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[94] Y. Tabata,et al. Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles. , 2014, Journal of biomedical nanotechnology.
[95] Michael Schmidt,et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. , 2010, ACS nano.
[96] Andreas Tauch,et al. CoryneRegNet 6.0—Updated database content, new analysis methods and novel features focusing on community demands , 2011, Nucleic Acids Res..
[97] Samuel A Wickline,et al. Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.
[98] Y. Tabata,et al. Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering. , 2014, Acta biomaterialia.
[99] M. Campiglio,et al. Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy , 2012, Journal of cellular physiology.